Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Allan Massie and Jacqueline Garonzik-Wang.
Connection Strength

5.627
  1. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):2170-2174.
    View in: PubMed
    Score: 0.243
  2. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123.
    View in: PubMed
    Score: 0.241
  3. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021 08 01; 105(8):e82-e83.
    View in: PubMed
    Score: 0.240
  4. Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine. Transplant Direct. 2021 Jul; 7(7):e713.
    View in: PubMed
    Score: 0.238
  5. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 06 01; 325(21):2204-2206.
    View in: PubMed
    Score: 0.237
  6. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021 05 04; 325(17):1784-1786.
    View in: PubMed
    Score: 0.236
  7. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 05 01; 105(5):e56-e57.
    View in: PubMed
    Score: 0.236
  8. Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study. Transplantation. 2021 05 01; 105(5):e52-e53.
    View in: PubMed
    Score: 0.236
  9. Response to "COVID-19 in SOT versus non-SOT". Am J Transplant. 2021 06; 21(6):2306.
    View in: PubMed
    Score: 0.233
  10. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort. Am J Transplant. 2021 07; 21(7):2498-2508.
    View in: PubMed
    Score: 0.233
  11. Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Am J Transplant. 2021 05; 21(5):1838-1847.
    View in: PubMed
    Score: 0.228
  12. Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States. Clin Transplant. 2020 12; 34(12):e14086.
    View in: PubMed
    Score: 0.226
  13. Effects of COVID-19 pandemic on pediatric kidney transplant in the United States. Pediatr Nephrol. 2021 01; 36(1):143-151.
    View in: PubMed
    Score: 0.226
  14. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020 11; 20(11):3131-3139.
    View in: PubMed
    Score: 0.224
  15. Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study. Am J Transplant. 2020 11; 20(11):2997-3007.
    View in: PubMed
    Score: 0.223
  16. Early Experiences With COVID-19 Testing in Transplantation. Transplant Direct. 2020 Jul; 6(7):e572.
    View in: PubMed
    Score: 0.222
  17. Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. 2020 07; 20(7):1809-1818.
    View in: PubMed
    Score: 0.220
  18. National Variation in Increased Infectious Risk Kidney Offer Acceptance. Transplantation. 2019 10; 103(10):2157-2163.
    View in: PubMed
    Score: 0.211
  19. Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients. Transplantation. 2019 06; 103(6):1267-1271.
    View in: PubMed
    Score: 0.206
  20. Pediatric deceased donor kidney transplant outcomes under the Kidney Allocation System. Am J Transplant. 2019 11; 19(11):3079-3086.
    View in: PubMed
    Score: 0.206
  21. Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States. Transplantation. 2018 04; 102(4):609-615.
    View in: PubMed
    Score: 0.190
  22. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2021 12 01; 105(12):e280-e281.
    View in: PubMed
    Score: 0.061
  23. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271.
    View in: PubMed
    Score: 0.061
  24. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138.
    View in: PubMed
    Score: 0.061
  25. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856.
    View in: PubMed
    Score: 0.060
  26. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1365-1366.
    View in: PubMed
    Score: 0.060
  27. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021 12; 40(12):1579-1588.
    View in: PubMed
    Score: 0.060
  28. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 09; 174(9):1330-1332.
    View in: PubMed
    Score: 0.059
  29. Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. Transplantation. 2021 01 01; 105(1):216-224.
    View in: PubMed
    Score: 0.058
  30. Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providers. Clin Transplant. 2019 08; 33(8):e13637.
    View in: PubMed
    Score: 0.052
  31. Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study. Transplantation. 2019 06; 103(6):1216-1223.
    View in: PubMed
    Score: 0.052
  32. Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study. JMIR Mhealth Uhealth. 2018 Oct 09; 6(10):e11192.
    View in: PubMed
    Score: 0.049
  33. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study. Transplantation. 2018 09; 102(9):1514-1519.
    View in: PubMed
    Score: 0.049
  34. Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study. Transplantation. 2018 07; 102(7):1148-1155.
    View in: PubMed
    Score: 0.048
  35. Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants. Transplantation. 2018 03; 102(3):471-477.
    View in: PubMed
    Score: 0.047
  36. MELD as a metric for survival benefit of liver transplantation. Am J Transplant. 2018 05; 18(5):1231-1237.
    View in: PubMed
    Score: 0.047
  37. Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys. Am J Transplant. 2018 03; 18(3):617-624.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.